Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-28 | Paul Chaney, Chairman of the Board, has served as a director since September 2007. He is co-founder, President & CEO of PanOptica, Inc, a private venture-backed biopharmaceutical company... Mr. Chaney has over 30 years of experience in the biopharmaceutical and ophthalmic medical device industry, including a variety of senior management positions at Pharmacia Corporation. |
| 2017-04-28 | Mr. Chaney earned a double BA in English and Biological Sciences from the University of Delaware. We believe Mr. Chaneys qualifications to sit on our board of directors include his executive leadership experience. |
| 2018-05-29 | Mr. Chaney earned a double BA in English and Biological Sciences from the University of Delaware. |
| 2019-04-30 | Paul Chaney, Chairman of the Board, has served as a director since September 2007. He is co-founder, President & CEO of PanOptica, Inc, a private venture-backed biopharmaceutical company... Mr. Chaney has over 30 years of experience in the biopharmaceutical and ophthalmic medical device industry... Mr. Chaney earned a double BA in English and Biological Sciences from the University of Delaware. |
| 2020-04-29 | Mr. Chaney earned a double BA in English and Biological Sciences from the University of Delaware. We believe Mr. Chaney’s qualifications to sit on our board of directors include his executive leadership experience, including 20 years leading major ophthalmology businesses. |
| 2021-04-30 | Mr. Chaney has over 30 years of experience in the biopharmaceutical and ophthalmic medical device industry, including a variety of senior management positions at Pharmacia Corporation. |
| 2022-08-08 | Paul Chaney |
| 2022-08-15 | Paul Chaney, Chairman, has served as a director since September 2007. He is co-founder, President & CEO of PanOptica, Inc, a private venture-backed biopharmaceutical company... Mr. Chaney has over 30 years of experience in the biopharmaceutical and ophthalmic medical device industry... Mr. Chaney earned a double BA in English and Biological Sciences from the University of Delaware. |
| 2023-04-28 | Mr. Chaney has over 30 years of experience in the biopharmaceutical and ophthalmic medical device industry, including a variety of senior management positions at Pharmacia Corporation. |
| 2023-07-21 | Director Compensation Table lists Paul Chaney as a director with no indication of software or technical background. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-19